Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Wirden

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|July 26, 2005
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar studyPhilippe Flandre, Anne-Geneviève Marcelin, Juliette Pavie, et al.
Antiviral Therapy|September 4, 2012
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapyRuxandra Calin, Luc Paris, Anne Simon, et al.
AIDS (London, England)|August 24, 2010
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretroviralsSlim Fourati, Isabelle Malet, Mawuena Binka, et al.
AIDS (London, England)|December 9, 2010
Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 yearsCathia Soulie, Sidonie Lambert-Niclot, Marc Wirden, et al.
AIDS (London, England)|September 27, 2005
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patientsJade Ghosn, Marc Wirden, Nadine Ktorza, et al.
AIDS (London, England)|December 4, 2008
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patientsMarc Wirden, Sidonie Lambert-Niclot, Anne-Genevieve Marcelin, et al.
AIDS (London, England)|January 25, 2003
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patientsJade Ghosn, Claire Lamotte, Hocine Ait-Mohand, et al.
Antiviral Therapy|September 13, 2006
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistanceAna Canestri, Jade Ghosn, Marc Wirden, et al.
AIDS (London, England)|April 2, 2005
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitutionMarc Wirden, Isabelle Malet, Anne Derache, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2025
Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIVBenjamin Kably, Roland Tubiana, Jade Ghosn, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|July 26, 2005
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar studyPhilippe Flandre, Anne-Geneviève Marcelin, Juliette Pavie, et al.
Antiviral Therapy|September 4, 2012
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapyRuxandra Calin, Luc Paris, Anne Simon, et al.
AIDS (London, England)|August 24, 2010
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretroviralsSlim Fourati, Isabelle Malet, Mawuena Binka, et al.
AIDS (London, England)|December 9, 2010
Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 yearsCathia Soulie, Sidonie Lambert-Niclot, Marc Wirden, et al.
AIDS (London, England)|September 27, 2005
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patientsJade Ghosn, Marc Wirden, Nadine Ktorza, et al.
AIDS (London, England)|December 4, 2008
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patientsMarc Wirden, Sidonie Lambert-Niclot, Anne-Genevieve Marcelin, et al.
AIDS (London, England)|January 25, 2003
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patientsJade Ghosn, Claire Lamotte, Hocine Ait-Mohand, et al.
Antiviral Therapy|September 13, 2006
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistanceAna Canestri, Jade Ghosn, Marc Wirden, et al.
AIDS (London, England)|April 2, 2005
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitutionMarc Wirden, Isabelle Malet, Anne Derache, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2025
Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIVBenjamin Kably, Roland Tubiana, Jade Ghosn, et al.
Pageof 10